title: Multiple myeloma associated with porphyria cutanea tarda: a possible role of bortezomib?
authors.forename: Miguel
authors.initials: M
authors.lastname: Cabanillas
authors.forename: Carmen
authors.initials: C
authors.lastname: Peteiro
authors.forename: Jaime
authors.initials: J
authors.lastname: Toribio
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000175:diagnosis; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib